trending Market Intelligence /marketintelligence/en/news-insights/trending/8OUS5YjkGTDcyJNwpZ8_sw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Cardiovascular Systems buys artery device from Gardia Medical

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Cardiovascular Systems buys artery device from Gardia Medical

Cardiovascular Systems Inc. acquired Gardia Medical Ltd.'s Wirion embolic protection system and related assets.

The Wirion embolic protection system is used to capture debris associated with all types of peripheral vascular intervention procedures, or PVI, to treat peripheral artery disease.

PVI refers to minimally invasive procedures that remove plaque and enable blood to flow through arteries without surgically opening any limbs.

The device was granted Europe's CE mark in June 2015 and U.S. Food and Drug Administration clearance in March 2018.

The acquisition is set to improve Cardiovascular Systems' portfolio of products to save limbs and improve outcomes for patients undergoing complex peripheral interventions, according to the company.

Gardia, a wholly owned unit of Israel's Allium Medical Solutions Ltd., will retain rights to the device for angioplasty and stenting procedures in carotid arteries.

St. Paul, Minn.-based Cardiovascular Systems develops and manufactures devices to treat vascular and coronary diseases.